A Dilemma for Governments: How to Pay for Million-Dollar Therapies
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
Source: NYT Health - Category: Consumer Health News Authors: Rebecca Robbins, Stephanie Nolen and Dado Galdieri Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Genetic Engineering Babies and Infants Genetics and Heredity Children and Childhood Suits and Litigation (Civil) Spinal Muscular Atrophy Disabilities Novartis AG Brazil Zolgen Source Type: news
More News: Babies | Brazil Health | Budgets | Children | Disability | Genetics | Health | Health Insurance | Insurance | Managed Care | Spinal Muscular Atrophy